— Know what they know.
Not Investment Advice

DXCM NASDAQ

DexCom, Inc.
1W: -8.6% 1M: -9.3% 3M: +5.0% YTD: +18.1% 1Y: +10.6% 3Y: -8.7% 5Y: -41.9%
$78.56
-0.01 (-0.01%)
After Hours: $79.46 (+0.90, +1.15%)
Weekly Expected Move ±5.2%
$70 $74 $78 $82 $86
NASDAQ · Healthcare · Medical - Devices · Tech Score Sell · Power 48 · $29.6B mcap · 376M float · 1.22% daily turnover · Short 45% of daily vol
Credit Risk of going bust: lower than 80% of companies Debt: 4.5% of company value Bonds: $105.4M held by 25 funds → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.29 (down 99.6%), DexCom, Inc. would be worth roughly what it owes.
Total debt $1.40B against a stock market value of $29.65B.
Distance to default 9.72 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $621.4M (short-term plus half of long-term), stock volatility 40.4%; Altman Z 7.02. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Balance Sheet Trends

Total Assets
$6.3B -2.2% ▼
5Y CAGR: +8.1%
Total Liabilities
$3.6B -18.0% ▼
5Y CAGR: +7.8%
Shareholders Equity
$2.7B +30.6% ▲
5Y CAGR: +8.5%
Cash & Investments
$2.0B -22.5% ▼
5Y CAGR: -5.9%
Total Debt
$1.4B -46.3% ▼
5Y CAGR: -5.5%
Net Debt
$472M -76.2% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$1.1B$642M$566M$606M$918M
Short-Term Investments$1.7B$1.8B$2.2B$2.0B$1.1B
Cash & ST Investments$2.7B$2.5B$2.7B$2.6B$2.0B
Net Receivables$517M$752M$988M$1.0B$1.3B
Inventory$357M$307M$560M$543M$629M
Other Current Assets$27M$37M$64M$58M$49M
Total Current Assets$3.7B$3.7B$4.4B$4.3B$4.0B
Property, Plant & Equip.$890M$1.1B$1.2B$1.4B$1.6B
Goodwill & Intangibles$58M$199M$160M$126M$95M
Long-Term Investments$0$19M$38M$119M$218M
Other Non-Current Assets$10M$28M$36M$54M$61M
Total Non-Current Assets$1.2B$1.7B$1.8B$2.2B$2.3B
Total Assets$4.9B$5.4B$6.3B$6.5B$6.3B
— Liabilities —
Accounts Payable$189M$238M$276M$345M$344M
Short-Term Debt$0$773M$0$1.2B$0
Deferred Revenue$2M$10M$18M$8M$8M
Other Current Liabilities$48M$48M$46M$56M$55M
Total Current Liabilities$721M$1.8B$1.6B$2.9B$2.1B
Long-Term Debt$2.0B$1.2B$2.4B$1.2B$1.2B
Other Non-Current Liab.$11M$45M$60M$80M$83M
Total Non-Current Liabilities$2.2B$1.4B$2.6B$1.4B$1.5B
Total Liabilities$2.9B$3.3B$4.2B$4.4B$3.6B
— Equity —
Common Stock$400K$400K$400K$400K$400K
Retained Earnings$139M$480M$1.0B$1.6B$2.4B
Accumulated OCI$500K-$12M-$17M-$8M$115M
Total Stockholders Equity$2.0B$2.1B$2.1B$2.1B$2.7B
Total Liabilities & Equity$4.9B$5.4B$6.3B$6.5B$6.3B
— Key Metrics —
Total Debt$2.2B$2.1B$2.6B$2.6B$1.4B
Net Debt$1.1B$1.5B$2.0B$2.0B$472M
Total Investments$1.7B$1.8B$2.2B$2.1B$1.3B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms